Pfizer has already profited billions of dollars from the COVID-19 pandemic, and it plans to do so for years to come via annual vaccinations and sales of its antiviral pill Paxlovid.
The Biden administration on Wednesday announced a $3.2 billion deal to purchase 105 million doses of Pfizer’s COVID-19 vaccine for a fall vaccination campaign, with options to buy up to 300 million doses.
A leading advisor to President Joe Biden on supply chains is an alum of several World Economic Forum climate change initiatives, who additionally served as a former fellow at a think tank chaired by Hunter Biden.